← Evidence map

ArticleNature2020

TRIM37 controls cancer-specific vulnerability to PLK4 inhibition.

Franz Meitinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

91 papers cite itlatest 60 shown

2020
…
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32908304